Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

OB Cadherin Antikörper

CDH11 Reaktivität: Human, Ratte WB, IHC, IHC (fro), ICC Wirt: Maus Monoclonal 16A unconjugated
Produktnummer ABIN335403
  • Target Alle OB Cadherin (CDH11) Antikörper anzeigen
    OB Cadherin (CDH11) (Cadherin 11 (CDH11))
    Reaktivität
    • 77
    • 38
    • 23
    • 4
    • 4
    • 4
    • 4
    Human, Ratte
    Wirt
    • 52
    • 22
    • 6
    • 1
    Maus
    Klonalität
    • 59
    • 22
    Monoklonal
    Konjugat
    • 40
    • 5
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser OB Cadherin Antikörper ist unkonjugiert
    Applikation
    • 63
    • 37
    • 10
    • 6
    • 6
    • 5
    • 5
    • 4
    • 4
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunocytochemistry (ICC)
    Spezifität
    Human and rat.
    Aufreinigung
    Protein A affinity column
    Immunogen
    16A is a mouse monoclonal IgG1 antibody obtained by fusion of SP2/0 mouse myeloma cells with spleen cells from a mouse immunized with affinity purified extracellular domain of human cadherin-11-GST fusion protein.
    Klon
    16A
    Isotyp
    IgG1
    Top Product
    Discover our top product CDH11 Primärantikörper
  • Applikationshinweise
    16A recognizes the extracellular domain of cadherin-11. 16A is suitable for immunoblotting, immunocytochemistry and immunohistochemistry on frozen sections when using a PBS buffer containing 0.1 mM CaCl 2 and 0.1 mM MgCl 2 . Optimal antibody dilution should be determined by titration, recommended range is 1:25 - 1:50 for immunohistochemistry with avidin-biotinylated horseradish peroxidase complex (ABC) as detection reagent, and 1:25 - 1:250 for immunoblotting applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Lagerung
    4 °C
  • Tomita, van Bokhoven, van Leenders, Ruijter, Jansen, Bussemakers, Schalken: "Cadherin switching in human prostate cancer progression." in: Cancer research, Vol. 60, Issue 13, pp. 3650-4, (2000) (PubMed).

    Bussemakers, Van Bokhoven, Tomita, Jansen, Schalken: "Complex cadherin expression in human prostate cancer cells." in: International journal of cancer. Journal international du cancer, Vol. 85, Issue 3, pp. 446-50, (2000) (PubMed).

  • Target
    OB Cadherin (CDH11) (Cadherin 11 (CDH11))
    Andere Bezeichnung
    OB-Cadherin / Cadherin-11 (CDH11 Produkte)
    Synonyme
    cad11 antikoerper, cdhob antikoerper, osf-4 antikoerper, Xcad-11 antikoerper, MGC108014 antikoerper, OB-cadherin antikoerper, cadherin-11 antikoerper, Cad11 antikoerper, cdhvn antikoerper, vnc antikoerper, CAD11 antikoerper, CDHOB antikoerper, OB antikoerper, OSF-4 antikoerper, cadherin 11 antikoerper, cadherin 11, type 2, OB-cadherin (osteoblast) antikoerper, cadherin 11 S homeolog antikoerper, CDH11 antikoerper, cdh11 antikoerper, Cdh11 antikoerper, cdh11.S antikoerper
    Hintergrund
    Cadherins constitute a family of transmembrane glycoproteins involved in Ca 2+ -dependent cell-cell interactions. The members of this family are differentially expressed in various tissues. They function in the maintenance of tissue integrity and morphogenesis. The cadherins generally contain five extracellular repeats, a transmembrane domain and a cytoplasmic tail that binds to the catenin family of cytoskeletal anchoring proteins which also function as signal transducers. The extracellular domains are responsible for the specificity of homophilic interactions between cells expressing the same cadherin. Cadherins are divided into type I and type II subgroups. Type I cadherins include epithelial cadherin (E-cadherin, cadherin-1 or uvomorulin), neural cadherin (N-cadherin or cadherin-2), placental cadherin (P-cadherin or cadherin-3) and retinal cadherin (R-cadherin or cadherin-4). Kidney cadherin (K-cadherin or cadherin-6) and osteoblast cadherin (OB-cadherin or cadherin-11) are type II cadherins. The progression of carcinomas is associated with the loss of epithelial morphology and a concomitant acquisition of a more mesenchymal phenotype, which is thought to contribute to the invasive and/or metastatic behavior. A putative role for cadherin-11 in these late stages of tumor progression is based on the fact that migration of mesenchymal cells is facilitated when cadherin-11 is highly expressed.
Sie sind hier:
Kundenservice